K2M Group (KTWO) Growth Driven by New products and Expanding Distribution; Needham & Company Cuts Price Target to $25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
K2M Group Holdings, Inc. Reports Third Quarter Revenue Growth of 16.7% in Constant Currency and Increases Fiscal Year 2015 Revenue Guidance Range
November 3, 2015 4:09 PM ESTLEESBURG, Va., Nov. 3, 2015 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive technologies and techniques, today reported financial results for the third quarter ended September 30, 2015.
Third Quarter Financial Summary:
Total reported revenue of $55.0 million, up 15.5% year-over-year. Total revenue increased 16.7% year-over-year on a constant currency basis. Domestic revenue of $39.5 million, up 14.8% year-over-year U.S. Complex Spine growth of 15.5% year-over-year U.S. Minimally Invasive Surgery (MIS) growth of... MoreK2M Group Holdings, Inc. Reports Third Quarter Revenue Growth of 16.7% in Constant Currency and Increases Fiscal Year 2015 Revenue Guidance Range
November 3, 2015 4:09 PM ESTLEESBURG, Va., Nov. 3, 2015 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive technologies and techniques, today reported financial results for the third quarter ended September 30, 2015.
Third Quarter Financial Summary:
Total reported revenue of $55.0 million, up 15.5% year-over-year. Total revenue increased 16.7% year-over-year on a constant currency basis. Domestic revenue of $39.5 million, up 14.8% year-over-year U.S. Complex Spine growth of 15.5% year-over-year U.S. Minimally Invasive Surgery (MIS) growth of... More